Novel medicine to prevent fungal infections.
D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001228:Aspergillosis / Q000517:prevention & control*; D002177:Candidiasis / Q000517:prevention & control*; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology; D014230:Triazoles / Q000009:adverse effects / Q000627:therapeutic use*
D000935:Antifungal Agents; D014230:Triazoles; C101425:posaconazole